← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Glaxosmithkline
King Of Prussia, PA
$11,783,413
Total funding
5
Grants
Funding mix
By agency
NIH$11,783,413 · 5
By mechanism
UC1$11,731,413 · 3
RC1$52,000 · 2
Investigators at Glaxosmithkline
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Tafenoquine, A New Drug for Malaria Prevention &Control$7,031,061
UC1 · FY2000 · AI
Novel cell-culture derived split influenza vaccine$3,489,073
UC1 · FY2004 · AI
Thiolactomycin Acid Derivatives as Novel Antibacterials$1,211,279
UC1 · FY2000 · AI
Challenge Grant--Joint Ventures$26,000
RC1 · FY2000 · AI
TAFENOQUINE, A NOVEL DRUG FOR MALARIA TRANSMISSION-BLOCK$26,000
RC1 · FY2000 · AI